Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis.
Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis.
复制标题
19009年大流行期间心理健康问题的患病率:系统评价和荟萃分析。
DOI:
10.1016/j.jad.2020.11.117
复制
发表时间:
2021-02-15
影响因子:
6.6
通讯作者:
Wang X
中科院分区:
文献类型:
--
作者:
Wu T;Jia X;Shi H;Niu J;Yin X;Xie J;Wang X
The global COVID-19 pandemic has generated major mental and psychological health problems worldwide. We conducted a meta-analysis to assess the prevalence of depression, anxiety, distress, and insomnia during the COVID-19 pandemic. We searched online biomedical databases (PubMed, Embase, Web of Science, Ovid, CNKI, and Wanfang Data) and preprint databases (SSRN, bioRxiv, and MedRxiv) for observational studies from January 1, 2020 to March 16, 2020 investigating the prevalence of mental health problems during the COVID-19 pandemic. We retrieved 821 citations from the biomedical databases and 53 citations from the preprint databases: 66 studies with 221,970 participants were included in our meta-analysis. The overall pooled prevalence of depression, anxiety, distress, and insomnia was 31.4%, 31.9%, 41.1% and 37.9%, respectively. Noninfectious chronic disease patients, quarantined persons, and COVID-19 patients had a higher risk of depression (Q=26.73, p<0.01) and anxiety (Q=21.86, p<0.01) than other populations. The general population and non-medical staff had a lower risk of distress than other populations (Q=461.21, p< 0.01). Physicians, nurses, and non-medical staff showed a higher prevalence of insomnia (Q=196.64, p<0.01) than other populations. All included studies were from the early phase of the global pandemic. Additional meta-analyses are needed to obtain more data in all phases of the pandemic. The COVID-19 pandemic increases the mental health problems of the global population, particularly health care workers, noninfectious chronic disease patients, COVID-19 patients, and quarantined persons. Interventions for mental health are urgently needed for preventing mental health problems.
登录
查看更多内容
影响因子:
11.8
作者:
Hawryluck L;Gold WL;Robinson S;Pogorski S;Galea S;Styra R
通讯作者:
Styra R
影响因子:
16.2
作者:
Egede, LE;Zheng, DY
通讯作者:
Zheng, DY
影响因子:
3.8
作者:
Jeong H;Yim HW;Song YJ;Ki M;Min JA;Cho J;Chae JH
通讯作者:
Chae JH
DOI:
10.1016/0197-2456(86)90046-2
发表时间:
1986-09-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
DERSIMONIAN, R;LAIRD, N
通讯作者:
LAIRD, N
影响因子:
2.3
作者:
Ali, Inayat
通讯作者:
Ali, Inayat